SWITZERLAND > UK based GSK (GlaxoSmithKline) is set to buyout Novartis’ 36.5% stake in the Consumer Healthcare Joint Venture for $13 billion

gsk logo UK based GSK is all set to buyout Switzerland based Novartis stake in the Consumer Healthcare Joint venture for $13 billion. Formed as part of the three part transaction between GSK and Novartis in 2014, Consumer Healthcare Joint Venture’s 100% ownership by GSK enables GSK shareholders to capture full value of future performance. According to Emma Walmsley, Chief Executive Officer, More …